OneTest
OneTest
OneTest™ helps detect cancers earlier, at more treatable stages with one simple blood test. A simple blood test for multiple cancers, harnesses the power of Artificial Intelligence to help identify the disease at an earlier, more treatable stage.
WHAT IS OneTest™?
OneTest™ is among the first multi-cancer screening panels to harness the power of AI to improve the accuracy of tumor marker tests to help identify 20+ types of cancer.
Based around a panel of tumor markers such as PSA, CEA, AFP, CA-125 and others, OneTest™ can aid in the early detection of many types of cancer, including those not commonly screened for such as lung, liver, pancreas, etc. OneTest™ is powered by real-world, cancer-screening results from tens of thousands of people.
WHY USE OneTest™?
For most cancers, early detection can save lives. OneTest™ is one of the most affordable tools to help detect cancers early.
Recent studies have demonstrated that genetics only accounts for around 5% of cancers.
Those concerned about their risk of cancer, even with little or no family history may benefit from routine cancer marker testing. This approach has become standard practice in Japan, Korea, China and throughout East Asia where nearly all adults receive checkups that include many of the biomarkers in OneTest™.
The test requires a doctor’s authorization and a venous blood draw. Acute Alternative is an affiliate doctor’s that can perform this exam. Schedule an appointment today!